BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2415808)

  • 1. Drug pharmacokinetics in thyroid dysfunction.
    Rodighiero V
    Minerva Endocrinol; 1985; 10(2):97-113. PubMed ID: 2415808
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug metabolism in thyroid disease.
    Eichelbaum M
    Clin Pharmacokinet; 1976; 1(5):339-50. PubMed ID: 797503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of thyroid dysfunction on drug pharmacokinetics.
    Shenfield GM
    Clin Pharmacokinet; 1981; 6(4):275-97. PubMed ID: 6166422
    [No Abstract]   [Full Text] [Related]  

  • 4. Unaltered metabolism of phenytoin in thyroid disorders.
    Mølholm Hansen J; Skovsted L; Kampmann JP; Lumholtz BI; Siersbaek-Nielsen K
    Acta Pharmacol Toxicol (Copenh); 1978 May; 42(5):343-6. PubMed ID: 581029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
    Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
    Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of thyroid status on plasma half-life of antipyrine in man.
    Eichelbaum M; Bodem G; Gugler R; Schneider-Deters D; Dengler HJ
    N Engl J Med; 1974 May; 290(19):1040-2. PubMed ID: 4821905
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs.
    Bell JM; Russell CJ; Nelson JK; Kelly JG; McDevitt DG
    Br J Clin Pharmacol; 1977 Feb; 4(1):79-82. PubMed ID: 14661
    [No Abstract]   [Full Text] [Related]  

  • 8. Amiodarone pharmacokinetics. III. Influence of thyroid dysfunction on amiodarone absorption and disposition.
    Weir SJ; Ueda CT
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1026-32. PubMed ID: 3418508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hypothyroidism and hyperthyroidism on dipyrone metabolism in man.
    Brunk SF; Combs SP; Miller JD; Delle M; Wilson WR
    J Clin Pharmacol; 1974; 14(5-6):271-9. PubMed ID: 4364273
    [No Abstract]   [Full Text] [Related]  

  • 10. Age-related aspects of pharmacodynamics.
    Zapadnjuk VI; Kuprash LP; Bezverkhaya IS; Zaika MU; Oranskaya SA
    Z Alternsforsch; 1984; 39(2):83-6. PubMed ID: 6145257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riboflavin absorption in children with thyroid disorders.
    Levy G; MacGillivray MH; Procknal JA
    Pediatrics; 1972 Dec; 50(6):896-900. PubMed ID: 4636455
    [No Abstract]   [Full Text] [Related]  

  • 12. [A study of the kinetics of cardiac glycosides in the human organism].
    van Zwieten PA
    Ned Tijdschr Geneeskd; 1971 Jan; 115(4):157-62. PubMed ID: 4926491
    [No Abstract]   [Full Text] [Related]  

  • 13. Antipyrine half-life in hyperthyroidism.
    Obel AO; Ng'ang'a J; Gitau W
    East Afr Med J; 1981 Apr; 58(4):258-62. PubMed ID: 7261979
    [No Abstract]   [Full Text] [Related]  

  • 14. [Introduction to clinical pharmacodynamics and pharmacokinetics of cardiac glycosides].
    Kudrin AN; Namakanov BA; Davydova ON
    Sov Med; 1981; (11):70-4. PubMed ID: 7038899
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction between metronidazole and drugs eliminated by oxidative metabolism.
    Jensen JC; Gugler R
    Clin Pharmacol Ther; 1985 Apr; 37(4):407-10. PubMed ID: 3979002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.
    Feely J
    Clin Pharmacokinet; 1983; 8(1):1-16. PubMed ID: 6132696
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered plasma half-lives of antipyrine, propylthiouracil, and methimazole in thyroid dysfunction.
    Vesell ES; Shapiro JR; Passananti T; Jorgensen H; Shively CA
    Clin Pharmacol Ther; 1975 Jan; 17(1):48-56. PubMed ID: 1122669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of four drugs in malnourished children.
    Mehta S; Nain CK; Sharma B; Mathur VS
    Drug Nutr Interact; 1982; 1(3):205-11. PubMed ID: 6821389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs for hypothyroidism and hyperthyroidism.
    Medical Letter, Inc
    Treat Guidel Med Lett; 2006 Apr; 4(44):17-24. PubMed ID: 16554701
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
    Sawada Y; Hanano M; Sugiyama Y; Iga T
    J Pharmacokinet Biopharm; 1985 Oct; 13(5):477-92. PubMed ID: 3938813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.